Literature DB >> 3189572

Naloxone alters organ perfusion during endotoxin shock in conscious rats.

W R Law1, J L Ferguson.   

Abstract

Antagonism of endogenous opioids has been shown to improve survival time, increase blood pressure, and attenuate acidosis during endotoxin shock. However, some of the most severe problems associated with this condition arise from the circulatory disturbances that occur. We investigated the circulatory effects of naloxone during endotoxin shock as they relate to hemodynamic parameters in conscious, unrestrained rats. Blood flow and hemodynamic variables were measured in male, Sprague-Dawley rats (300-400 g) 24 h after surgical preparation. Rats were challenged with either 10 mg/kg Escherichia coli endotoxin (100% lethal dose) or intravenous saline. Measurements were made at 0, 10, 30, and 60 min postchallenge. Naloxone (2 mg/kg) or saline was given as a treatment (intravenous bolus) at 25 min postchallenge. Cardiac output and blood distribution (%CO) and flow were measured with radiolabeled microspheres. Cardiac output was depressed and total peripheral resistance was elevated 10 min into endotoxin shock. Naloxone treatment improved blood pressure significantly during endotoxin shock, as would be expected with the observed increase in total peripheral vascular resistance and no significant change in cardiac output. Improved perfusion of skeletal muscle is a likely explanation for lower serum lactate levels that have been reported to occur in this model after naloxone administration. Our data also indicate that naloxone may improve cardiac efficiency and does not interfere with maintenance of global cerebral blood flow. Collectively, these effects would contribute to the observed improved survival time after naloxone treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3189572     DOI: 10.1152/ajpheart.1988.255.5.H1106

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Naloxone pretreatment prevents kidney injury after liver ischemia reperfusion injury.

Authors:  Mohammad Ashrafzadeh Takhtfooladi; Mehran Shahzamani; Ahmad Asghari; Aris Fakouri
Journal:  Int Urol Nephrol       Date:  2016-04-07       Impact factor: 2.370

2.  (+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors.

Authors:  Eva M Medina-Rodriguez; Kenner C Rice; Eléonore Beurel; Richard S Jope
Journal:  Brain Behav Immun       Date:  2020-08-26       Impact factor: 7.217

3.  Toll-Like Receptor-4 Antagonist (+)-Naloxone Confers Sexually Dimorphic Protection From Inflammation-Induced Fetal Programming in Mice.

Authors:  Peck Yin Chin; Camilla Dorian; David J Sharkey; Mark R Hutchinson; Kenner C Rice; Lachlan M Moldenhauer; Sarah A Robertson
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

Review 4.  Renal blood flow in sepsis.

Authors:  Christoph Langenberg; Rinaldo Bellomo; Clive May; Li Wan; Moritoki Egi; Stanislao Morgera
Journal:  Crit Care       Date:  2005-05-24       Impact factor: 9.097

5.  Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth.

Authors:  Peck Yin Chin; Camilla L Dorian; Mark R Hutchinson; David M Olson; Kenner C Rice; Lachlan M Moldenhauer; Sarah A Robertson
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

Review 6.  Recent advances in the prevention of preterm birth.

Authors:  Jeff A Keelan; John P Newnham
Journal:  F1000Res       Date:  2017-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.